Literature DB >> 19886668

Dendrimers for vaccine and immunostimulatory uses. A review.

Peter M H Heegaard1, Ulrik Boas, Nanna Skall Sorensen.   

Abstract

Dendrimers are well-defined (monodisperse) synthetic globular polymers with a range of interesting chemical and biological properties. Chemical properties include the presence of multiple accessible surface functional groups that can be used for coupling biologically relevant molecules and methods that allow for precise heterofunctionalization of surface groups. Biologically, dendrimers are highly biocompatible and have predictable biodistribution and cell membrane interacting characteristics determined by their size and surface charge. Dendrimers have optimal characteristics to fill the need for efficient immunostimulating compounds (adjuvants) that can increase the efficiency of vaccines, as dendrimers can provide molecularly defined multivalent scaffolds to produce highly defined conjugates with small molecule immunostimulators and/or antigens. The review gives an overview on the use of dendrimers as molecularly defined carriers/presenters of small antigens, including constructs that have built-in immunostimulatory (adjuvant) properties, and as stand-alone adjuvants that can be mixed with antigens to provide efficient vaccine formulations. These approaches allow the preparation of molecularly defined vaccines with highly predictable and specific properties and enable knowledge-based vaccine design substituting the traditional empirically based approaches for vaccine development and production.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19886668     DOI: 10.1021/bc900290d

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  32 in total

1.  Carbohydrate antigen delivery by water soluble copolymers as potential anti-cancer vaccines.

Authors:  Qian Qin; Zhaojun Yin; Philip Bentley; Xuefei Huang
Journal:  Medchemcomm       Date:  2014-08-01       Impact factor: 3.597

Review 2.  Nanoparticle systems for cancer vaccine.

Authors:  Ru Wen; Afoma C Umeano; Yi Kou; Jian Xu; Ammad Ahmad Farooqi
Journal:  Nanomedicine (Lond)       Date:  2019-02-26       Impact factor: 5.307

3.  Enhanced bioactivity of internally functionalized cationic dendrimers with PEG cores.

Authors:  Lorenzo Albertazzi; Frauke M Mickler; Giovanni M Pavan; Fabrizio Salomone; Giuseppe Bardi; Mariangela Panniello; Elizabeth Amir; Taegon Kang; Kato L Killops; Christoph Bräuchle; Roey J Amir; Craig J Hawker
Journal:  Biomacromolecules       Date:  2012-11-27       Impact factor: 6.988

Review 4.  Dendrimer nanoscaffolds for potential theranostics of prostate cancer with a focus on radiochemistry.

Authors:  Su-Tang Lo; Amit Kumar; Jer-Tsong Hsieh; Xiankai Sun
Journal:  Mol Pharm       Date:  2013-01-24       Impact factor: 4.939

5.  Toward Personalized Peptide-Based Cancer Nanovaccines: A Facile and Versatile Synthetic Approach.

Authors:  Hamilton Kakwere; Elizabeth S Ingham; Riley Allen; Lisa M Mahakian; Sarah M Tam; Hua Zhang; Matthew T Silvestrini; Jamal S Lewis; Katherine W Ferrara
Journal:  Bioconjug Chem       Date:  2017-10-13       Impact factor: 4.774

6.  Evaluation of the synthesis of sialic acid-PAMAM glycodendrimers without the use of sugar protecting groups, and the anti-HIV-1 properties of these compounds.

Authors:  Russell Clayton; Janee Hardman; Celia C LaBranche; Katherine D McReynolds
Journal:  Bioconjug Chem       Date:  2011-09-06       Impact factor: 4.774

7.  End-group distributions of multiple generations of spin-labeled PAMAM dendrimers.

Authors:  Karl B Sebby; Eric D Walter; Robert J Usselman; Mary J Cloninger; David J Singel
Journal:  J Phys Chem B       Date:  2011-04-06       Impact factor: 2.991

8.  Dendrimer-conjugated peptide vaccine enhances clearance of Chlamydia trachomatis genital infection.

Authors:  Ingrid S Ganda; Qian Zhong; Mirabela Hali; Ricardo L C Albuquerque; Francine F Padilha; Sandro R P da Rocha; Judith A Whittum-Hudson
Journal:  Int J Pharm       Date:  2017-05-22       Impact factor: 5.875

9.  Boosting immunity to small tumor-associated carbohydrates with bacteriophage qβ capsids.

Authors:  Zhaojun Yin; Marta Comellas-Aragones; Sudipa Chowdhury; Philip Bentley; Katarzyna Kaczanowska; Lbachir Benmohamed; Jeffrey C Gildersleeve; M G Finn; Xuefei Huang
Journal:  ACS Chem Biol       Date:  2013-03-29       Impact factor: 5.100

10.  N-acetylgalactosamino dendrons as clearing agents to enhance liver targeting of model antibody-fusion protein.

Authors:  Barney Yoo; Sarah M Cheal; Geralda Torchon; Anna Dilhas; Guangbin Yang; Jun Pu; Blesida Punzalan; Steven M Larson; Ouathek Ouerfelli
Journal:  Bioconjug Chem       Date:  2013-11-18       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.